XML 89 R65.htm IDEA: XBRL DOCUMENT v3.3.1.900
Financial Instruments and Derivative Financial Instruments (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Jun. 30, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Derivative [Line Items]        
Discussion of Objectives for Using Foreign Currency Derivative Instruments   The Company uses forward foreign currency exchange contracts to partially reduce risks related to transactions denominated in foreign currencies. These contracts hedge firm commitments and forecasted transactions relating to cash flows associated with sales and purchases denominated in non-functional currencies. The Company offsets fair value amounts related to foreign currency exchange contracts executed with the same counterparty. Changes in the fair value of forward foreign currency exchange contracts that are effective as hedges are recorded in OCI. Deferred gains or losses are reclassified from OCI to the Consolidated Statements of Operations in the same period as the gains or losses from the underlying transactions are recorded and are generally recognized in cost of sales. The ineffective portion of derivatives that are classified as hedges is immediately recognized in earnings and is also generally recognized in cost of sales.    
Objectives for Using Net Investment Hedging Instruments   Certain of the Company's forward foreign currency contracts were designated as net investment hedges of the Company's net investment in its foreign subsidiaries. For derivative instruments that were designated and qualified as a hedge of a net investment in foreign currency, the gain or loss was reported in other comprehensive income as part of the cumulative translation adjustment to the extent it is effective. The Company utilizes the forward-rate method of assessing hedge effectiveness. Any ineffective portion of net investment hedges would be recognized in the Consolidated Statements of Operations in the same period as the change.    
Discussion of Objectives for Using Interest Rate Derivative Instruments   The Company has interest rate swap agreements that do not meet the criteria for hedge accounting. The terms of the interest rate swap agreements require the Company to receive a variable interest rate based upon the three-month LIBOR and pay a fixed interest rate. Changes in the fair value of interest rate swap agreements are immediately recognized in earnings and included on the line “Other” in the “Other (income) expense” section of the unaudited condensed consolidated statements of operations.    
Long-term Debt   $ 32.1 $ 19.2  
Long-term Debt, Fair Value   32.1 19.2  
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net   (0.1) (0.8) $ 0.0
Cash Flow Hedging [Member]        
Derivative [Line Items]        
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net   (0.1) (0.8) 0.0
Cash Flow Hedging [Member] | Foreign Exchange Contract [Member]        
Derivative [Line Items]        
Derivative, Notional Amount   634.7 510.8  
Derivative, Fair Value, Net   8.8 5.6  
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months   5.8    
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net   (0.1) 0.0 0.0
Cash Flow Hedging [Member] | Interest Rate Contract [Member]        
Derivative [Line Items]        
Derivative, Notional Amount   100.0    
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net $ (0.8) 0.0 (0.8) $ 0.0
Interest Rate Derivatives, at Fair Value, Net   $ (0.3) $ 0.3